207 related articles for article (PubMed ID: 15996035)
1. Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan--Iran.
Mohammad Alizadeh AH; Alavian SM; Jafari K; Yazdi N
World J Gastroenterol; 2005 Jul; 11(26):4085-9. PubMed ID: 15996035
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of hepatitis C infection in a Brazilian prison: identification of risk factors for infection.
Guimarães T; Granato CF; Varella D; Ferraz ML; Castelo A; Kallás EG
Braz J Infect Dis; 2001 Jun; 5(3):111-8. PubMed ID: 11506773
[TBL] [Abstract][Full Text] [Related]
3. Molecular epidemiology of HIV, HBV, HCV, and HTLV-1/2 in drug abuser inmates in central Javan prisons, Indonesia.
Prasetyo AA; Dirgahayu P; Sari Y; Hudiyono H; Kageyama S
J Infect Dev Ctries; 2013 Jun; 7(6):453-67. PubMed ID: 23771289
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of Hepatitis C Virus among Prisoners in Lakan Prison, North of Iran, Is There Still a Concern?
Mohtasham-Amiri Z; Rezvani SM; Ashoori F; Behboodi M; Toosi H; Jafari-Shakib R
Arch Iran Med; 2021 Oct; 24(10):765-770. PubMed ID: 34816699
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of selected sexually and blood-borne infections in Injecting drug abuser inmates of bandar abbas and roodan correction facilities, Iran, 2002.
Davoodian P; Dadvand H; Mahoori K; Amoozandeh A; Salavati A
Braz J Infect Dis; 2009 Oct; 13(5):356-8. PubMed ID: 20428635
[TBL] [Abstract][Full Text] [Related]
6. [Infection with hepatitis C virus in a prison environment. A prospective study in Loos-lez-Lille, France].
Hedouin V; Gosset D
Gastroenterol Clin Biol; 1998 Jan; 22(1):55-8. PubMed ID: 9762167
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for prevalent hepatitis C virus-infection among inmates in a state prison system in Mexico.
Belaunzarán-Zamudio PF; Mosqueda-Gomez JL; Macias-Hernandez A; Sierra-Madero JG; Ahmed S; Beyrer C
PLoS One; 2017; 12(6):e0179931. PubMed ID: 28654650
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and risk factors for HBV and HCV in prisoners in Iran: a national bio-behavioural surveillance survey in 2015.
Moradi G; Gouya MM; Azimizan Zavareh F; Mohamadi Bolbanabad A; Darvishi S; Aghasadeghi MR; Nabavi M; Alasvand R; Tashakorian M; Nouri B; Rahmani K; Molaei L
Trop Med Int Health; 2018 Jun; 23(6):641-649. PubMed ID: 29698576
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of hepatitis C virus infection and risk factors of drug using prisoners in Guilan province.
Mohtasham Amiri Z; Rezvani M; Jafari Shakib R; Jafari Shakib A
East Mediterr Health J; 2007; 13(2):250-6. PubMed ID: 17684845
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran.
Zamani S; Ichikawa S; Nassirimanesh B; Vazirian M; Ichikawa K; Gouya MM; Afshar P; Ono-Kihara M; Ravari SM; Kihara M
Int J Drug Policy; 2007 Oct; 18(5):359-63. PubMed ID: 17854723
[TBL] [Abstract][Full Text] [Related]
11. Correlation between HIV and HCV in Brazilian prisoners: evidence for parenteral transmission inside prison.
Burattini M; Massad E; Rozman M; Azevedo R; Carvalho H
Rev Saude Publica; 2000 Oct; 34(5):431-6. PubMed ID: 11105105
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C, hepatitis B and HIV infection among Egyptian prisoners: seroprevalence, risk factors and related chronic liver diseases.
Mohamed HI; Saad ZM; Abd-Elreheem EM; Abd-ElGhany WM; Mohamed MS; Abd Elnaeem EA; Seedhom AE
J Infect Public Health; 2013 Jun; 6(3):186-95. PubMed ID: 23668463
[TBL] [Abstract][Full Text] [Related]
13. Burden of HIV, Syphilis, and Hepatitis B and C Among Inmates in a Prison State System in Mexico.
Belaunzaran-Zamudio PF; Mosqueda-Gomez JL; Macias-Hernandez A; Rodríguez-Ramírez S; Sierra-Madero J; Beyrer C
AIDS Res Hum Retroviruses; 2017 Jun; 33(6):524-533. PubMed ID: 28094553
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of hepatitis C infection and associated risk factors among addicted prisoners in Sari-Iran.
Zakizad M; Salmeh F; Yaghoobi T; Yaghoubian M; Nesami MB; Esmaeeli Z; Vaezzadeh N; Shahmohammadi S; Modanloo S; Sadeghian AA; Abdolmanafi SJ; Mohammadpour RA; Siamian H; Khosravi A
Pak J Biol Sci; 2009 Jul; 12(14):1012-8. PubMed ID: 19947179
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for hepatitis C infection and perception of antibody status among male prison inmates in the Hepatitis C Incidence and Transmission in Prisons Study cohort, Australia.
Gates JA; Post JJ; Kaldor JM; Pan Y; Haber PS; Lloyd AR; Dolan KA;
J Urban Health; 2004 Sep; 81(3):448-52. PubMed ID: 15273267
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and correlates of hepatitis C virus infection among inmates entering the California correctional system.
Ruiz JD; Molitor F; Sun RK; Mikanda J; Facer M; Colford JM; Rutherford GW; Ascher MS
West J Med; 1999 Mar; 170(3):156-60. PubMed ID: 10214102
[TBL] [Abstract][Full Text] [Related]
17. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy.
Babudieri S; Longo B; Sarmati L; Starnini G; Dori L; Suligoi B; Carbonara S; Monarca R; Quercia G; Florenzano G; Novati S; Sardu A; Iovinella V; Casti A; Romano A; Uccella I; Maida I; Brunetti B; Mura MS; Andreoni M; Rezza G
J Med Virol; 2005 Jul; 76(3):311-7. PubMed ID: 15902712
[TBL] [Abstract][Full Text] [Related]
18. [Seroprevalence of hepatitis C virus infection at the time of entry to prison in the prison population in the north-east of Spain].
Martín Sánchez V; Ferrer Castro V; Pallas Álvarez JR; Alonso Herrero LE; Andrés Honorato M; Coterillo González MJ; García Marcos LS; González Márquez J; Hernández Alonso I; LLanos Gallegos M; Mallada García E; Martínez Martínez ML; Morillo Pérez M; Pérez Martínez I; Valles Martínez J
Rev Esp Salud Publica; 1998; 72(1):43-51. PubMed ID: 9477715
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence study of HCV among hospitalized intravenous drug users in Ahvaz, Iran (2001-2006).
Alavi SM; Alavi L
J Infect Public Health; 2009; 2(1):47-51. PubMed ID: 20701860
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Prevalence of Hepatitis B, Hepatitis C, and HIV in Inmates with Drug-Related Convictions in Birjand, Iran in 2008.
Azarkar Z; Sharifzadeh G
Hepat Mon; 2010; 10(1):26-30. PubMed ID: 22308122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
